JPWO2020072428A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020072428A5
JPWO2020072428A5 JP2021542077A JP2021542077A JPWO2020072428A5 JP WO2020072428 A5 JPWO2020072428 A5 JP WO2020072428A5 JP 2021542077 A JP2021542077 A JP 2021542077A JP 2021542077 A JP2021542077 A JP 2021542077A JP WO2020072428 A5 JPWO2020072428 A5 JP WO2020072428A5
Authority
JP
Japan
Prior art keywords
seq
lys
dpr
poly
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021542077A
Other languages
English (en)
Japanese (ja)
Other versions
JP7505788B2 (ja
JP2022511995A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/053967 external-priority patent/WO2020072428A1/en
Publication of JP2022511995A publication Critical patent/JP2022511995A/ja
Publication of JPWO2020072428A5 publication Critical patent/JPWO2020072428A5/ja
Application granted granted Critical
Publication of JP7505788B2 publication Critical patent/JP7505788B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021542077A 2018-10-01 2019-10-01 C9orf72に由来するジペプチドリピートタンパク質に対して指向化されたペプチド免疫原コンストラクト Active JP7505788B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862739794P 2018-10-01 2018-10-01
US62/739,794 2018-10-01
PCT/US2019/053967 WO2020072428A1 (en) 2018-10-01 2019-10-01 Peptide immunogen constructs directed against dipeptide repeat proteins from c9orf72

Publications (3)

Publication Number Publication Date
JP2022511995A JP2022511995A (ja) 2022-02-01
JPWO2020072428A5 true JPWO2020072428A5 (enExample) 2022-10-05
JP7505788B2 JP7505788B2 (ja) 2024-06-25

Family

ID=70055826

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021542077A Active JP7505788B2 (ja) 2018-10-01 2019-10-01 C9orf72に由来するジペプチドリピートタンパク質に対して指向化されたペプチド免疫原コンストラクト

Country Status (8)

Country Link
US (1) US20210347866A1 (enExample)
EP (1) EP3861007A4 (enExample)
JP (1) JP7505788B2 (enExample)
CN (1) CN113227116A (enExample)
AU (1) AU2019354291A1 (enExample)
CA (1) CA3114657A1 (enExample)
TW (1) TWI781347B (enExample)
WO (1) WO2020072428A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4034550A4 (en) * 2019-09-23 2023-09-27 University of Florida Research Foundation, Incorporated VACCINE THERAPY FOR RAN PROTEIN DISEASES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025468A (en) 1998-06-20 2000-02-15 United Biomedical, Inc. Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides
US6906169B2 (en) * 2001-05-25 2005-06-14 United Biomedical, Inc. Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
GB0510763D0 (en) * 2005-05-27 2005-06-29 London School Hygiene & Tropical Medicine Malaria vaccines
PT2948777T (pt) * 2013-01-22 2019-09-26 Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E V Proteínas de repetição por dipeptídeos como alvo terapêutico em doenças neurodegenerativas com expansão de hexanucleotídico repetido
WO2014116865A1 (en) * 2013-01-24 2014-07-31 Mayo Foundation For Medical Education And Research Methods and materials for detecting c9orf72 hexanucleotide repeat expansion positive frontotemporal lobar degeneration or c9orf72 hexanucleotide repeat expansion positive amyotrophic lateral sclerosis
US9102752B2 (en) 2013-03-15 2015-08-11 United Biomedical, Inc. Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type
BR112016007751A2 (pt) * 2013-10-11 2017-09-12 Ionis Pharmaceuticals Inc composições para modulação de expressão de c9orf72
CN108064248B (zh) * 2014-09-30 2022-03-15 生物控股有限公司 人源抗二肽重复(dpr)抗体

Similar Documents

Publication Publication Date Title
JP2021508672A5 (enExample)
JP2001502658A (ja) 非樹状中心骨格ペプチド担体
JP5276598B2 (ja) コイルドコイル構造を有するリポペプチドビルディングブロック、リポペプチドヘリックスバンドル、合成ウイルス様粒子、および医薬製剤
JP2006504653A5 (enExample)
RU2005104565A (ru) Конъюгаты грелин-носитель
JP2003529319A (ja) HIV−1gp41を標的化する広範に中和する抗体を誘発する方法
JP5890407B2 (ja) 呼吸器合胞体ウイルス抗原組成物および方法
JP2010512792A5 (enExample)
CN107098974B (zh) 一种融合蛋白及其应用
FR2718452A1 (fr) Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
CZ20011907A3 (cs) Částice jádra HBV s imunogenními sloľkami navázanými prostřednictvím peptidových ligandů
RU2007119319A (ru) Наборы антигенов полипептида, угнетающего секрецию желудка (gip), и их применение
JP2002524031A (ja) アレルギーの予防および/または治療のための化合物と方法
JP4024849B2 (ja) インフルエンザウイルスのサブユニット複合体
WO2003039225A3 (en) Antigen arrays comprising rankl for treatment of bone disease
CN104755619A (zh) 用于预防猪水肿病的疫苗
TWI507413B (zh) 脂質化多抗原表位疫苗
JPWO2020011972A5 (enExample)
JP2006519160A5 (enExample)
JPWO2020072428A5 (enExample)
AU732085B2 (en) Vaccine comprising antigens bound to carriers through labile bonds
JP2012502663A5 (enExample)
CN103087156B (zh) 口蹄疫病毒抗原多肽及疫苗
JP2001513120A (ja) ペプチドを含むポリマー
CN1482916A (zh) 含有转化生长因子α的疫苗组合物